Renal cytochrome P450 ω-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1131-1137

  Oyekan, A O ^a   Youseff, T ^a   Fulton, D ^b   Quilley, J ^c   McGiff, J C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Dentistry of New Jersey New Jersey Medical School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYGENASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ISOLATED KIDNEY; KIDNEY METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE;

EID: 0032747358     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6786     Document Type: Article

References (40)

1. Moncada, S., Palmer, R.M.G., and Higgs, E.A. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:109-142.
2. Nathan, C. 1992. Nitric oxide is a secretory product of mammalian cells. FASEB J. 6:3051-3064.
3. Hurshman, A.R., and Marletta, M.A. 1995. Nitric oxide complexes of inducible nitric oxide synthase: spectral characterization and effects on catalytic activity. Biochemistry. 34:5627-5634.
4. Griscavage, J.M., Habbs, A.J., and Ignarro, L.J. 1995. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv. Pharmacol. 34:215-234.
5. Salvemini, D., et al. 1993. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:7240-7244.
6. Ferraz, J.G.P., et al. 1997. Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage. Gastroenterology. 113:195-204.
7. Wink, D.A., et al. 1993. Inhibition of cytochrome P450 by nitric oxide and a nitric oxide releasing agent. Arch. Biochem. Biophys. 300:115-123.
8. Stadler, J., et al. 1994. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. USA. 91:3559-3563.
9. Khatsenko, O.G., Gross, S.S., Rifkind, A.B., and Vane, J.R. 1993. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA. 90:11147-11151.
10. Alonso-Galicia, M., Drummond, H.A., Reddy, K.K., Falck, J.R., and Roman, R.R. 1997. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension. 29:320-325.
11. Sun, C.-W., et al. 1998. Nitric oxide 20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. Circ. Res. 83:1069-1079.
12. Kim, Y.M., Bergonia, H.A., Muller, C., Pitt, B.R., Watkins, W.D., and Lancaster, J.R., Jr. 1995. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270:5710-5713.
13. Mehl, M., Daiber, A., Herold, S., Shoun, H., and Ullrich, V. 1999. Peroxynitrite reaction with heme proteins. Nitric Oxide. 3:142-152.
14. Minamiyama, Y., et al. 1997. Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharmacol. Exp. Ther. 283:1479-1485.
15. McGiff, J.C., and Quilley, J. 1999. 20-HETE and the kidney: resolution of old problems and new beginnings. Am. J. Physiol. 46:R607-R623.
16. Schwartzman, M.L., Abraham, N.G., Carroll, M.A., Levere, R.D., and McGiff, J.C. 1986. Regulation of arachidonic acid metabolism by cytochrome P450 in rabbit kidney. Biochem. J. 238:283-290.
17. McGiff, J.C. 1991. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31:339-369.
18. Navar, L.G. 1998. Integrating multiple paracrine regulators of renal microvascular dynamics. Am. J. Physiol. 274:F433-F444.
19. Zou, A.-P., et al. 1994. Effect of P450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. 266:F934-F941.
20. Zou, A.-P., et al. 1994. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 266:F275-F282.
21. Escalante, B., Erlij, D., Falck, J.R., and McGiff, J.C. 1991. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 251:799-802.
22. Ribeiro, C.M., Dubay, G.R., Falck, J.R., and Mandel, L.J. 1994. Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway. Am. J. Physiol. 266:F497-F505.
23. Oyekan, A.O., and McGiff, J.C. 1998. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450-derived arachidonate metabolites. Br. J. Pharmacol. 125:1065-1073.
24. Campbell, W.B., Gebremedhin, D., Pratt, P.F., and Harder, D.R. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78:415-423.
25. Fulton, D., McGiff, J.C., and Quilley, J. 1998. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J. Pharmacol. Exp. Ther. 287:497-503.
26. Fulton, D., McGiff, J.C., and Quilley, J. 1991. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol. 107:722-725.
27. Makita, K., et al. 1994. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest. 94:2414-2420.
28. Oyekan, A.O., McGiff, J.C., and Quilley, J. 1991. Cytochrome P450-dependent vasodilator responses to arachidonic acid in the isolated perfused kidney of the rat. Circ. Res. 68:958-965.
29. Oyekan, A.O., Balazy, M., and McGiff, J.C. 1997. Renal oxygenases: differential contribution to vasoconstriction induced by endothelin-1 and angiotensin II. Am. J. Physiol. 273:R293-R300.
30. Oyekan, A.O. 1995. The suppression by lipopolysaccharide of cytochrome P450-dependent renal vasodilation in the rat is mediated by nitric oxide. Eur. J. Pharmacol. 277:123-132.
31. Harris, R.C. 1996. The macula densa: recent developments. J. Hypertens. 14:815-822.
32. Wilcox, C.S., and Welch, W.J. 1996. TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int. Suppl. 55:S9-S13.
33. Garg, U.C., and Hassid, A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
34. Stec, D.E., Trolliet, M.R., Krieger, J.E., Jacob, H.J., and Roman, R.J. 1996. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. Hypertension. 27:1329-1336.
35. Omata, K., Abraham, N.G., and Schwartzman, M.L. 1992. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am. J. Physiol. 262:F591-F599.
36. Okita, J.R., Castle, P.J., and Okita, R.T. 1993. Characterization of cytochromes P450 in liver and kidney of rats treated with di-(2-ethylhexyl)phthalate. J. Biochem. Toxicol. 8:135-144.
37. Wang, M.-H., et al. 1999. Contribution of cytochrome P450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am. J. Physiol. 276:F246-F253.
38. Zou, A.P., and Cowley, A.W. 1997. Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension. 29:194-198.
39. Mattson, D.L., and Bellehumeur, T.G. 1996. Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension. 28:297-303.
40. Mattson, D.L., and Higgins, D.J. 1996. Influence of dietary sodium intake on renal medullary nitric oxide synthase and L-NAME hypertension. Hypertension. 27:688-692.